Full history for every metric is available with a Kvantra account
Stock profile
Dimension Therapeutics, Inc. (DMTX)
Current price
5.95 USD-0.42%
Last close 6 Nov 2017Benchmarks
Key financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | - | - | 8 | 11 | 17 |
| Operating profit | $m | -49 | -56 | |||||
| Net profit | $m | - | - | - | - | -35 | -49 | -56 |
| EPS reported | $ | -1.96 | -2.23 | |||||
| Operating cashflow per share | $ | - | -1.90 | |||||
| Capex per share | $ | - | 0.27 | |||||
| FCF per share | $ | - | -2.17 | |||||
| Free cash flow | $m | -54 | -59 | |||||
| Net debt | $m | -71 | -29 | |||||
| Book value equity | $m | 60 | 20 | |||||
| Book value per share | $ | 2.40 | 0.81 | |||||
| Number of shares | m | 25.02 | 25.02 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.82 | 2.48 | |||||
| P/S LTM | x | 9.49 | 0.00 | |||||
| P/FCF LTM | x | -2.00 | 0.00 | |||||
| EV/EBITDA LTM | x | -1.80 | 0.50 | |||||
| EV/Sales LTM | x | - | -2.07 | |||||
| Earnings Yield LTM | % | - | -32.92% | |||||
| FCF Yield | % | -49.96% | - | |||||
| Quality | ||||||||
| ROE | % | - | -59.21% | |||||
| ROIC | % | - | -64.89% | |||||
| Operating margin | % | - | -427.60% | |||||
| Gross margin | % | - | 100.00% | |||||
| FCF/Sales | % | - | -473.89% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +48.01% | +71.26% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | -8.32 | -11.29 | |||||
| Net Debt/EBITDA | x | - | 0.50 | |||||
| EBIT/Net interest | x | - | 0.00 | |||||
| Net debt/market cap | % | -65.63% | - | |||||
| Net debt/Equity | x | -1.19 | -1.40 | |||||
| Gross debt/equity | x | 0.11 | 0.25 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
DM
Dimension Therapeutics, Inc. (DMTX)
DMTX · NASDAQ · Healthcare
5.95 USD-0.42%
Benchmarks
Financialsin USD
20152016TTM
Total revenue $m81117
Operating profit $m-49-56
Net profit $m-35-49-56
EPS reported $-1.96-2.23
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free